| Literature DB >> 17035746 |
J Berman1.
Abstract
New lipid formulations of amphotericin B--AmBisome, Amphotec, and Abelcet--have dramatically decreased the toxicity associated with amphotericin B and have made this group of agents the treatment of choice for visceral leishmaniasis. An agent of a completely different chemical class, the aminoglycoside aminosidine, was 97% curative in India. This agent too may be used for visceral leishmaniasis.Entities:
Year: 1998 PMID: 17035746
Source DB: PubMed Journal: Curr Opin Infect Dis ISSN: 0951-7375 Impact factor: 4.915